Recent advancements in breast reconstruction have brought forth innovative techniques and technologies, offering improved outcomes and patient satisfaction. Advanced surgical procedures like microsurgical flap reconstruction enable more natural-looking and long-lasting results. Additionally, the use of 3D imaging and virtual reality aids in personalized treatment planning. Emerging features include autologous fat grafting for contour refinement and developing custom-made implants. These advancements expand the applications of breast reconstruction, providing women with more choices for restoring their physical and emotional well-being after breast cancer surgery.
Access Full Report @ https://www.databridgemarketresearch.com/zh/reports/middle-east-and-africa-breast-reconstruction-market
Data Bridge Market Research analyses that the Middle East and Africa Breast Reconstruction Market is valued at USD 567 million in 2021 and is expected to reach USD 917.44 million by 2029, registering a CAGR of 6.2% during the forecast period of 2022 to 2029. Technological advancements in breast reconstruction techniques, such as autologous tissue reconstruction and implant-based procedures, have improved surgical outcomes and patient satisfaction, thus driving the market’s growth.
Key Findings of the Study
Growing awareness and acceptance are expected to drive the market's growth rate
The increasing awareness about breast reconstruction options and the improved acceptance of these procedures by both patients and healthcare providers are driving factors for the growth of the breast reconstruction market. As information about the benefits and success rates of breast reconstruction becomes more accessible, patients are more inclined to consider it as a viable option after breast cancer treatment. Additionally, healthcare providers are better equipped to discuss and recommend breast reconstruction, leading to more patients opting for these procedures, thus contributing to market expansion.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Materials Co., Ltd (China), ALLERGAN (Ireland), Johnson & Johnson Private Limited (U.S), GC Aesthetics (Ireland), Laboratories Arion (France), HansBioMed (South Korea), Sientra, Inc. (U.S), IDeal Implant Incorporated (U.S), Integra LifeSciences (U.S), RTI Surgical (U.S), Sebbin (France)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The Middle East and Africa breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure, and end user.
- On the basis of product the market is segmented into breast implants, tissue expanders, and acellular dermal matrix.
- On the basis of type the market is segmented into unilateral, bilateral.
- On the basis of shape the market is segmented into round implants, anatomical implants.
- On the basis of technology the market is segmented into inframammary, peri-areolar, trans-axillary, transumbilical.
- On the basis of placement the market is segmented into dual-plane insertion, subglandular insertion, submuscular insertion.
- On the basis of procedure the market is segmented into immediate procedures, delayed procedures, revision procedures.
- On the basis of end user the market is segmented into hospitals, cosmetology clinics, ambulatory surgical centers, others.
Major Players
Data Bridge Market Research recognizes the following companies as the major Middle East and Africa breast reconstruction market players in Middle East and Africa breast reconstruction market are POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Materials Co., Ltd (China), ALLERGAN (Ireland), Johnson & Johnson Private Limited (U.S)
Market Developments
- In 2022, Mentor Worldwide LLC (Johnson & Johnson) received the US FDA approved a new MENTOR Memory Gel boost breast implant.
- In 2021, POLYTECH Health & Aesthetics received US FDA approval for the company’s textured breast implants (macrotextured and polyurethane-coated implants).
- In 2020, Sientra received US FDA pre-market approval for its OPUS-branded breast implant products.
Regional Analysis
Geographically, the countries covered in the Middle East and Africa breast reconstruction market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
For more detailed information about the Middle East and Africa breast reconstruction market report, click here – https://www.databridgemarketresearch.com/zh/reports/middle-east-and-africa-breast-reconstruction-market
